Galenica AG
SIX:GALE

Watchlist Manager
Galenica AG Logo
Galenica AG
SIX:GALE
Watchlist
Price: 76.95 CHF -0.97%
Market Cap: 3.8B CHF
Have any thoughts about
Galenica AG?
Write Note

Gross Margin
Galenica AG

27.7%
Current
27%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.7%
=
Gross Profit
1.1B
/
Revenue
3.8B

Gross Margin Across Competitors

No Stocks Found

Galenica AG
Glance View

Market Cap
3.8B CHF
Industry
Health Care

In the picturesque landscape of Switzerland, Galenica AG operates as a stalwart in the healthcare sector, seamlessly bridging the gap between pharmaceutical production and retail distribution. Born from a deep-rooted legacy in delivering health solutions, Galenica combines its prowess in logistics with an extensive network of pharmacies spread across the country. The magic of Galenica's operations lies in its unique dual structure. On one hand, it operates a robust logistics arm, supplying a wide array of medicines to healthcare providers, hospitals, and pharmacies. On the other hand, it runs its own retail pharmacy chains, such as Amavita and Sun Store, alongside an e-commerce platform, which make pharmaceutical care more accessible and customer-friendly for the Swiss populace. Galenica's profitability thrives on this diversified business model. By owning the supply chain from logistics to retail, the company maximizes efficiency and reduces costs, positioning itself as a leader in the Swiss pharmaceutical market. Revenue streams flow from wholesale distribution contracts, retail pharmacy sales, and a growing presence in digital health services. Furthermore, in its operations, Galenica integrates a customer-centric philosophy, leveraging data analytics to optimize stock management and personalize customer experiences—effectively enhancing earnings and customer loyalty. Through meticulous execution and strategic expansion, Galenica ensures that it remains an indispensable player in Switzerland's healthcare framework.

GALE Intrinsic Value
70.65 CHF
Overvaluation 8%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
27.7%
=
Gross Profit
1.1B
/
Revenue
3.8B
What is the Gross Margin of Galenica AG?

Based on Galenica AG's most recent financial statements, the company has Gross Margin of 27.7%.

Back to Top